BRAINLIFE Brain Tumor Medical Database

TreatmentAnticonvulsant Pathology


Neurology. 2004 Jan 27;62(2):299-300. (Case Report)


Abstract

Reversible language regression as an adverse effect of topiramate treatment in children

Gross-Tsur V, Shalev RS

Neuropediatric Unit, Shaare Zedek Medical Center, Jerusalem, Israel.

Profound language regression developed in three children with epilepsy 4 to 28 weeks after beginning topiramate (TPM). 
TPM was administered as an adjunctive antiepileptic drug at doses of 2.5 to 6.0 mg/kg/day. 
Language functions recovered while TPM was being reduced in dose or stopped.

PMID: 14745074 [PubMed - in process]

Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14745074&dopt=Abstract


 

This website is certified by Health On the Net Foundation. Click to verify. HOMECURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTSBRAIN TUMOR MEDICAL DATABASE SERVICES TREATMENT OPTIONS FOR GLIOBLASTOMA
DATABASE by Section: Classification | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Management | Prognosis | Psychosocial Aspects | Stem Cells | Treatment
DATABASE by Tumor: Glioblastoma | Medulloblastoma | Other TumorsSERVICES: About BrainLife | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications | Search | SiteMap
This site complies with the HONcode standard for trustworthy health information: verify here bottom